Cochrane Abstracts
Botulinum toxin type A therapy for blepharospasm
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Botulinum Toxin Type a Therapy for Blepharospasm." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437152/all/Botulinum_toxin_type_A_therapy_for_blepharospasm.
Botulinum toxin type A therapy for blepharospasm. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437152/all/Botulinum_toxin_type_A_therapy_for_blepharospasm. Accessed February 8, 2025.
Botulinum toxin type A therapy for blepharospasm. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437152/all/Botulinum_toxin_type_A_therapy_for_blepharospasm
Botulinum Toxin Type a Therapy for Blepharospasm [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437152/all/Botulinum_toxin_type_A_therapy_for_blepharospasm.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Botulinum toxin type A therapy for blepharospasm
ID - 437152
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437152/all/Botulinum_toxin_type_A_therapy_for_blepharospasm
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
